Survey: Medtech firms could cut jobs, R&D to manage device tax

02/22/2013 | MassDevice.com (Boston)

An Emergo Group survey of 650 senior medtech executives found that 11% would shrink their workforce to help manage the costs of the 2.3% medical device tax, while about 12% would cut their research and development funding. Meanwhile, more than 40% of respondents said they would deal with the tax by raising product prices.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park